Jonathan Monson - 02 Aug 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP and CFO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
02 Aug 2025
Net transactions value
-$55,656
Form type
4
Filing time
04 Aug 2025, 17:43:43 UTC
Previous filing
02 Jul 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Monson Jonathan EVP and CFO 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 04 Aug 2025 0001779170

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +1,090 +3.1% $0.000000 35,817 02 Aug 2025 Direct F1
transaction BSX Common Stock Tax liability $55,656 -528 -1.5% $105.41 35,289 02 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -1,090 -100% $0.000000 0 02 Aug 2025 Common Stock 1,090 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant.